SpaceX Just Fell Below Its IPO Price. Here's What Happens Next, According to History.

SpaceX’s IPO priced at $135 after raising $85B+ (overallotment included) has reversed course: the stock fell below $135 this week and is down more than 13% since the launch. The article highlights weaker near-term profitability from the AI unit, where $12B in capital spending last year contributed to a net loss, even as Starlink revenue reached $11.4B of $18B total. Using past IPO patterns, it suggests an average ~13% drop in the first three months, implying SpaceX could hover around ~$139 if history repeats, with the upcoming earnings report a key near-term catalyst.

Analysis

When a newly listed, story-heavy name immediately loses momentum, the market is usually not debating the addressable market; it is pricing the probability that future funding needs will outrun near-term monetization. That matters because every incremental dollar of capex now carries a higher equity cost of capital, so valuation can compress faster than operating results deteriorate. For SPCX, the key question is whether recurring revenue can start funding innovation before the market decides the business is a financing vehicle rather than a compounder.

The second-order read-through is negative for the broader long-duration growth complex, especially capital-intensive names where the path to self-funding is unclear. RIVN is the closest public-market analogue: if investors are punishing SPCX for heavy investment and delayed profitability, they will be even less patient with companies that have weaker recurring revenue and less pricing power. In contrast, profitable AI beneficiaries like NVDA should be relatively insulated, because the market will prefer businesses that monetize capex rather than consume it.

The contrarian view is that the selloff may be more technical than fundamental: post-IPO price discovery, limited float, and early investor de-risking can create a misleading signal before the first real operating checkpoint. The thesis is falsified if the next earnings cycle shows subscriber growth re-accelerating while cash burn moderates; in that case, the market will likely re-rate SPCX over 1-3 months. Absent that, expect dead money to modest downside for 1-3 months, with the structural multiple reset lasting 6-18 months until free-cash-flow visibility improves.

Key Decisions for Investors

• Do not chase SPCX on weakness; wait for the first earnings print or a stabilization base. If revenue quality and capex intensity do not improve, the stock remains a candidate for further multiple compression over the next 1-3 months.
• If options are liquid, buy SPCX 1-3 month put spreads on any relief rally; risk is defined, and the trade is aimed at the next catalyst rather than trying to predict day-to-day price action.
• Use RIVN as the cleaner public-market hedge against the same 'capital intensity without near-term self-funding' factor. Short RIVN vs. a basket of profitable large-cap tech like NVDA into the next growth-stock wobble; the spread should work if the market keeps rewarding cash generation over narrative.
• Stay long NVDA on weakness relative to SPCX-style names. The market is likely to keep paying up for monetized AI exposure while discounting speculative AI spend, so NVDA should be the higher-quality expression of the same thematic demand.
• Set an alert for the next SPCX quarterly update: if subscriber growth slows or capex stays elevated, trim any exposure immediately; if cash burn narrows materially, the post-IPO de-rating thesis weakens quickly.